146 related articles for article (PubMed ID: 26259268)
1. [COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA].
Kashirina OS; Chernikova MI; Vasiliev YM
Zh Mikrobiol Epidemiol Immunobiol; 2015; (3):38-46. PubMed ID: 26259268
[TBL] [Abstract][Full Text] [Related]
2. [COLD-ADAPTED A/KRASNODAR/101/35/59 (H2N2) STRAIN--A PROMISING STRAIN-DONOR OF ATTENUATION FOR PROCURATION OF LIVE INFLUENZA VACCINES].
Markushin SG; Tsfasman TM; Terekhov AV; Lisovskaya KV; Akopova II
Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):27-32. PubMed ID: 26829850
[TBL] [Abstract][Full Text] [Related]
3. [Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant].
Markushin SG; Gendon IuZ; Krivtsov GG; Akopova II; Sukhno AS; Pereverzev AD
Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):29-34. PubMed ID: 21061574
[TBL] [Abstract][Full Text] [Related]
4. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
5. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
Isakova-Sivak I; Korenkov D; Smolonogina T; Tretiak T; Donina S; Rekstin A; Naykhin A; Shcherbik S; Pearce N; Chen LM; Bousse T; Rudenko L
Virology; 2017 Jan; 500():209-217. PubMed ID: 27829176
[TBL] [Abstract][Full Text] [Related]
7. [Live attenuated and inactivated influenza vaccines: data from direct comparative studies].
Kashirina OS; Vasil'ev IuM
Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):103-19. PubMed ID: 24738303
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice.
Wareing MD; Watson JM; Brooks MJ; Tannock GA
J Med Virol; 2001 Sep; 65(1):171-7. PubMed ID: 11505460
[TBL] [Abstract][Full Text] [Related]
9. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
11. An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection.
Ni Y; Guo J; Turner D; Tizard I
Front Immunol; 2018; 9():1815. PubMed ID: 30140267
[TBL] [Abstract][Full Text] [Related]
12. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
Treanor JJ; Roth FK; Betts RF
J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
[TBL] [Abstract][Full Text] [Related]
14. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
Clements ML; Betts RF; Murphy BR
Lancet; 1984 Mar; 1(8379):705-8. PubMed ID: 6143042
[TBL] [Abstract][Full Text] [Related]
15. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
J Infect Dis; 1986 Jul; 154(1):121-7. PubMed ID: 3711685
[TBL] [Abstract][Full Text] [Related]
16. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
[TBL] [Abstract][Full Text] [Related]
17. [New cold-adapted donor strains for live influenza vaccine].
Gendon IuZ; Markushin SG; Tsfasman TM; Akopova II; Akhmatova NK; Koptiaeva IB
Vopr Virusol; 2013; 58(1):11-7. PubMed ID: 23785755
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
Edwards KM; Dupont WD; Westrich MK; Plummer WD; Palmer PS; Wright PF
J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
20. [Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].
Sergeeva MV; Kuznetsov VV; Kas'ianenko MA; Shaldzhian AA; Repko IA; Potapchuk MV; Romanova IuR; Tsybalova LM
Vopr Virusol; 2013; 58(6):36-9. PubMed ID: 24772645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
